PTGS2 and cancer: The critical role of inflammatory COX-2 and 5-LO and their biological products, prostaglandin and leukotrienes in inflammation and their ability to stimulate signalling pathways contributing to angiogenesis, tumor growth, and invasiveness, further highlights them as potential targets for cancer therapy.